Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima, Japan.
Department of Laboratory Medicine; Fukushima Medical University, Fukushima, Japan.
Thyroid. 2021 Nov;31(11):1683-1692. doi: 10.1089/thy.2021.0072.
The thyroid ultrasound examination (TUE) program was initiated among the residents of Fukushima Prefecture aged ≤18 years at the time of the Fukushima Dai-ichi Nuclear Power Plant accident. In this program, fine needle aspiration cytology (FNAC) was performed only in cases that conformed to the Japanese guidelines for the management of thyroid nodules. To analyze the suitability of the protocol in the TUE, we analyzed the implementation rate of FNAC and the detection rate of thyroid malignancy. There were 299,939 and 269,659 voluntary participants in the Preliminarily Baseline Survey (PLBS), first-round survey, and the first Full-scale Survey (FSS), second-round survey, of the TUE, respectively. FNAC is recommended for nodules with diameters 5.1-10.0 mm showing sonographic characteristics that are strongly suspicious for thyroid carcinoma; diameters 10.1-20.0 mm with characteristics that are suspicious for carcinoma; and all nodules with diameters >20 mm. In the PLBS and the first FSS, 1362 and 1382 cases with thyroid nodules sized ≥5.1 mm in diameter were found, respectively. The implementation rates of FNAC in the PLBS were 20.1%, 63.2%, and 87.7% of subjects with nodules sized 5.1-10.0, 10.1-20.0, and ≥20.1 mm in diameter, respectively. In the first FSS, the FNAC implementation rates were 7.3%, 26.0%, and 50.0% in the subjects with nodules with diameters 5.1-10.0, 10.1-20.0, and ≥20.1 mm, respectively. In the subjects who underwent FNAC, the detection rates of malignant and suspected malignant nodules were 21.4% and 34.1% in the PLBS and first FSS, respectively. In the first FSS, malignant or suspected malignant nodules were found in 0.63% and 0.40% of subjects who had nodules of diameters ≤5.0 mm and 5.1-10.0 mm in the PLBS, respectively. In contrast, in the subjects with nodules measuring ≥10.0 mm in diameter in the PLBS, no malignancies were detected. The use of a protocol that conformed to the Japanese guidelines led to a reduction in the FNAC implementation rate and an increase in the malignancy detection rate in smaller nodules. In addition, the use of this strategy enabled us to avoid detection failure of thyroid carcinomas >10.0 mm.
甲状腺超声检查(TUE)计划在福岛第一核电站事故发生时,在福岛县 ≤18 岁的居民中启动。在该计划中,仅在符合日本甲状腺结节管理指南的情况下进行细针抽吸细胞学检查(FNAC)。为了分析 TUE 中方案的适宜性,我们分析了 FNAC 的实施率和甲状腺恶性肿瘤的检出率。在 TUE 的初步基线调查(PLBS)、第一轮调查和第一轮全面调查(FSS)、第二轮调查中,分别有 299939 名和 269659 名志愿者参加。FNAC 推荐用于直径 5.1-10.0mm 的结节,超声特征强烈提示甲状腺癌;直径 10.1-20.0mm 伴有可疑癌特征;以及所有直径 >20mm 的结节。在 PLBS 和第一次 FSS 中,分别发现了 1362 例和 1382 例直径≥5.1mm 的甲状腺结节。PLBS 中直径 5.1-10.0mm、10.1-20.0mm 和≥20.1mm 结节患者 FNAC 的实施率分别为 20.1%、63.2%和 87.7%。在第一次 FSS 中,直径 5.1-10.0mm、10.1-20.0mm 和≥20.1mm 结节患者的 FNAC 实施率分别为 7.3%、26.0%和 50.0%。在接受 FNAC 的患者中,PLBS 和第一次 FSS 中恶性和可疑恶性结节的检出率分别为 21.4%和 34.1%。在第一次 FSS 中,PLBS 中直径≤5.0mm 和 5.1-10.0mm 的结节患者中,分别有 0.63%和 0.40%发现恶性或可疑恶性结节。相比之下,PLBS 中直径≥10.0mm 的结节患者中未发现恶性肿瘤。使用符合日本指南的方案导致 FNAC 实施率降低,较小结节的恶性肿瘤检出率升高。此外,该策略的使用使我们能够避免检测到直径>10.0mm 的甲状腺癌。